NBMA Validates National Biosafety Guidelines on Gene Editing in NigeriaDecember 16, 2020
The National Biosafety Management Agency (NBMA) of Nigeria has formally validated its National Biosafety Guidelines on Gene Editing and has presented them to the public.
NBMA Director General Dr Rufus Ebegba, while speaking during the validation exercise in Abuja on December 9, 2020, said that the Agency has been evolving and the Federal government is poised to drive the economy and the livelihood of the people. He noted that Nigeria has keyed in science and technology as major drivers of the economy, hence the need for the NBMA to ensure that gene editing and its products are safe and do not have an adverse impact on human health and the environment.
"We seriously believe that gene editing needs adequate regulation so that products developed will not be harmful to the environment, human health, plants, and animals. It is on that note that the need for the amendment of the NBMA Act 2015 to include emerging aspects of modern biotechnology in the area of synthetic biology, gene drive, gene editing, and biosecurity was made in 2019," said Dr. Ebegba. "The Federal Government is very proactive on the issue of modern technology. That is why the Federal Government through the NBMA decided to develop guidelines on gene editing," he added
The Director General said the NBMA, working with other sister agencies, has over the months worked on the development of these guidelines and they have gone through various internal and external reviews and processes.
"We have subjected these guidelines to national and international reviews and even scientists from research institutes reviewed them in a bid to make sure we come up with a robust document that will ensure proper regulation of gene editing and its products for food and feed processes, confinement, contained use, and commercial release," he explained.
Modupe Adeyemo, Program Officer for the Africa Development Agency (AUDA-NEPAD), shared that with the biosafety legal framework in place, the focus now is to put in place additional regulatory tools to ensure informed, effective, and efficient processes. She added that AUDA-NEPAD remains committed to forging strategic partnerships that will have a transformative impact on the continent. She exuded confidence that the validation of the gene editing guidelines will contribute to a sustainable and functional biosafety regulatory system in Nigeria.
For more information, contact Dr. Rufus Ebegba at firstname.lastname@example.org.
You might also like:
- Nigeria Commercializes Pod Borer Resistant Cowpea, its First GM Food Crop
- Nigeria Stresses Importance of Biotechnology for Food Security
- Nigeria Registers Biotech Cotton Varieties for Access to Farmers
The Crop Biotech Update is a weekly newsletter of ISAAA, a non-for-profit organization. The CBU is distributed for free to over 23,000 subscribers worldwide to inform them about the key developments in biosciences, especially in agricultural biotechnology. Your support will help us in our mission to feed the world with knowledge. You can help by donating as little as $10.
See more articles:
- WHO Calls for Actions to Encourage Acceptance and Uptake of COVID-19 Vaccines
News from Around the World
- ISAAA Short Course Highlights Relevance of Integrating Research, Science-based Regulation, and SciCom in Sustainable Agri Dev't
- ISAAA Shares 2019 Global Biotech Crop Adoption to Stakeholders in the Philippines and Arab Region
- Give a Gift of Knowledge
- Webinar: Biotech Crop Adoption in 2019 and Latin America's Experience
- NBMA Validates National Biosafety Guidelines on Gene Editing in Nigeria
- University of Florida Study Uncovers Vanilla DNA Mystery
- RNAi Pesticides Could Be the Next Big Tool in Agriculture
- US FDA Has Approved First GM Pig for People with Red Meat Allergies
- Chinese Scientists Develop Rice Variety Using Ion Beam Technology
- GM Tomato Enriched with L-DOPA Offers Affordable Medicine for Parkinson's Disease
- Soybean Gene Overexpression Offers Resistance to SDS
Plant Breeding Innovations
- Biotech Research Perceived With Caution Globally, but Most Support Gene Editing for Therapeutics
Subscribe to CBU: